Revenue (Tables)

6 Months Ended

Apr. 30, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:

	Three Months Ended April 30
	2020								2019
	Life Sciences and Applied Markets		Agilent CrossLab		Diagnostics and Genomics		Total		Life Sciences and Applied Markets		Agilent CrossLab		Diagnostics and Genomics		Total
	(in millions)
Revenue by Region
Americas	$	170	$	161	$	126	$	457	$	145	$	168	$	120	$	433
Europe	111		131		92		334		125		132		97		354
Asia Pacific	245		157		45		447		259		155		37		451
Total	$	526	$	449	$	263	$	1,238	$	529	$	455	$	254	$	1,238

	Six Months Ended April 30
	2020								2019
	Life Sciences and Applied Markets		Agilent CrossLab		Diagnostics and Genomics		Total		Life Sciences and Applied Markets		Agilent CrossLab		Diagnostics and Genomics		Total
	(in millions)
Revenue by Region
Americas	$	379	$	328	$	244	$	951	$	313	$	324	$	229	$	866
Europe	278		264		184		726		289		260		188		737
Asia Pacific	507		327		84		918		534		313		72		919
Total	$	1,164	$	919	$	512	$	2,595	$	1,136	$	897	$	489	$	2,522

The following table presents the company’s total revenue disaggregated by end markets and by revenue type:

	Three Months Ended				Six Months Ended
	April 30				April 30
	2020		2019		2020		2019
	(in millions)
Revenue by End Markets
Pharmaceutical and Biopharmaceutical	$	400	$	371	$	823	$	762
Chemical and Energy	267		300		579		608
Diagnostics and Clinical	200		193		394		380
Food	114		114		244		243
Academia and Government	115		114		256		230
Environmental and Forensics	142		146		299		299
Total	$	1,238	$	1,238	$	2,595	$	2,522
Revenue by Type
Instrumentation	$	491	$	491	$	1,084	$	1,058
Non-instrumentation and other	747		747		1,511		1,464
Total	$	1,238	$	1,238	$	2,595	$	2,522

Contract Liabilities and Changes in Balances

The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the six months ended April 30, 2020:

	Contract Liabilities
	(in millions)
Ending balance as of October 31, 2019	$	386
Net revenue deferred in the period	289
Revenue recognized that was included in the contract liability balance at the beginning of the period	(226		)
Change in deferrals from customer cash advances, net of revenue recognized	8
Currency translation and other adjustments	(5		)
Ending balance as of April 30, 2020	$	452